Neuro-Oncology Branch

Watch new Neuro-Oncology Branch video on NCI YouTube

Jan 10, 2019

The Neuro-Oncology Branch is comprised of an exceptional team of experts across scientific disciplines and medical specialties dedicated to developing new treatments for patients with brain and spine cancers using the latest technologies. Learn more about this department. Read more...

Watch new Neuro-Oncology Branch video on NCI YouTube
Best places to work

Glassdoor recognizes NIH as one of the best places to work

Dec 31, 2018

NIH has been recognized as one of the best places to work by Glassdoor and the Partnership for Public Service. Glassdoor rankings were “determined by the people who know these companies best - their employees.” The Partnership for Public Service rankings were determined by the views of more than 847,000 civil servants from 488 federal organizations on a wide range of workplace topics. Read more...

Glassdoor recognizes NIH as one of the best places to work
NCI connect

View the new NCI-CONNECT video on YouTube

Dec 27, 2018

NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumors) aims to advance the understanding of rare adult central nervous system (CNS) cancers by establishing and fostering patient-advocacy-provider partnerships and networks to improve approaches to care and treatment. Learn more about NCI-CONNECT through this new video. Read more...

View the new NCI-CONNECT video on YouTube
Horizons cover

New CCR publication, Horizons, is now available

Dec 18, 2018

As Nobel-Prize-winning physicist Niels Bohr once said, “Prediction is very difficult, especially about the future.” Yet, several areas of research that promise new understanding and treatments of cancer are coming into view. In this magazine, we highlight several areas of investigation likely to shape future research conducted in CCR. The collection in Horizons is by no means complete but seeks to capture some of the major areas that will influence our future work. Read more...

New CCR publication, Horizons, is now available
Human T-cell leukemia virus

Renewed research focus on the human T-cell leukemia virus

Nov 9, 2018

Human T-cell leukemia virus-1(HTLV-1) is the only known retrovirus to directly cause cancer in humans. Infection with this retrovirus affects millions of people worldwide, but currently there is neither a targeted antiretroviral therapy nor a vaccine available. “The discovery of novel preventive or therapeutic remedies for this retrovirus could relieve not only the suffering of HTLV-1 infected individuals but also augment understanding of other chronic infections with cancer viruses,” says Genoveffa Franchini, M. D., Senior Investigator in the CCR Vaccine Branch who has conducted pioneering work on the retrovirus. Read more...

Lung cancer cells

Lung Cancer Research

Nov 1, 2018

November is Lung Cancer Awareness Month. Our research portfolio includes investigators making important discoveries in lung cancer research.  Read more...

pancreatic cancer cells

Pancreatic Cancer Research

Nov 1, 2018

November is Pancreatic Cancer Awareness Month. We have many researchers, both in the basic and clinical disciplines, who are working on pancreatic cancer.  Learn more...

Perwez Hussain

Recap: The 5th NCI Pancreatic Cancer Symposium

Oct 15, 2018

The 5th NCI Pancreatic Cancer Symposium took place on October 2-3, 2018, and was attended by about 300 participants from across the United States and abroad. This year’s symposium was jointly organized by the NCI Pancreatic Cancer Interest Group and the Medical University of Gottingen, Germany. The symposium covered the latest advancements in the field and provided novel insights in the area of early detection, epidemiology, tumor biology including metabolic reprograming and inflammatory/immune signaling and tumor stromal interaction, and it highlighted the challenges in developing treatment strategies to improve patient outcomes.  Read more...

breast cancer in a dish

Breast Cancer Research

Oct 1, 2018

To recognize Breast Cancer Awareness Month this October, we are highlighting our researchers who are making discoveries in this field. Read more…

Lymphoma

Our leukemia and lymphoma research

Sep 4, 2018

September is leukemia and lymphoma awareness month. Lymphoma is a broad term for cancer that begins in cells of the lymph system. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Leukemia is a broad term for cancers of the blood cells. The type of leukemia depends on the type of blood cell that becomes cancer and whether it grows quickly or slowly. To learn more about our leukemia and lymphoma research, click here.

Pages